These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 11245391

  • 1. Newborn lung treatment poses risk of intestinal perforation.
    J Am Coll Surg; 2001 Mar; 192(3):425-6. PubMed ID: 11245391
    [No Abstract] [Full Text] [Related]

  • 2. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone.
    De Laet MH, Dassonville M, Johansson A, Lerminiaux C, Seghers V, Van den Eijnden S, Blum D, Vanderwinden JM.
    Eur J Pediatr Surg; 2000 Oct; 10(5):323-7. PubMed ID: 11194544
    [Abstract] [Full Text] [Related]

  • 3. Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants.
    Gordon PV, Young ML, Marshall DD.
    J Perinatol; 2001 Oct; 21(3):156-60. PubMed ID: 11503101
    [Abstract] [Full Text] [Related]

  • 4. Postnatal dexamethasone for lung disease of prematurity.
    Gordon PV.
    N Engl J Med; 2004 Jun 24; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218578
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB, Sauer H, Gortner L, Gräber S, Meyer S.
    Acta Paediatr; 2013 Oct 24; 102(10):e436. PubMed ID: 23819647
    [No Abstract] [Full Text] [Related]

  • 6. Fluid balance, respiratory status and limiting the risks of postnatal dexamethasone.
    Greenough A.
    Acta Paediatr; 2001 May 24; 90(5):592-3. PubMed ID: 11430727
    [No Abstract] [Full Text] [Related]

  • 7. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.
    Halliday H.
    J Pediatr; 2001 Jul 24; 139(1):163-4. PubMed ID: 11463049
    [No Abstract] [Full Text] [Related]

  • 8. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
    Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE.
    J Paediatr Child Health; 2004 Jul 24; 40(5-6):282-9. PubMed ID: 15151582
    [Abstract] [Full Text] [Related]

  • 9. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.
    Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F.
    Pediatr Res; 2006 Dec 24; 60(6):745-50. PubMed ID: 17065571
    [Abstract] [Full Text] [Related]

  • 10. Role of early post natal dexamethasone in respiratory distress syndrome.
    Locham KK, Dhawan M.
    Indian Pediatr; 1998 Sep 24; 35(9):932. PubMed ID: 10216614
    [No Abstract] [Full Text] [Related]

  • 11. Dexamethasone therapy interferes with the development of the neutrophil oxidative burst in vitro in very low birthweight infants.
    Ahmad M, Fleit HB, Golightly MG, La Gamma EF.
    Am J Perinatol; 2007 Apr 24; 24(4):223-5. PubMed ID: 17447193
    [Abstract] [Full Text] [Related]

  • 12. A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin.
    Gordon PV, Herman AC, Marcinkiewicz M, Gaston BM, Laubach VE, Aschner JL.
    J Pediatr Gastroenterol Nutr; 2007 Nov 24; 45(5):509-19. PubMed ID: 18030227
    [Abstract] [Full Text] [Related]

  • 13. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul 24; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 14. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar 24; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 15. Care of very low birth weight infants with respiratory distress syndrome: an evidence-based review.
    Carlo WA, Prince LS, St John EB, Ambalavanan N.
    Minerva Pediatr; 2004 Aug 24; 56(4):373-80. PubMed ID: 15457135
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous peritoneal drainage in the management of acute intestinal perforation.
    Atakent YS, Wasserman-Hoff R, Ozek E, Oygur N, Ginsburg HB.
    J Perinatol; 1997 Aug 24; 17(1):46-51. PubMed ID: 9069065
    [Abstract] [Full Text] [Related]

  • 17. Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists.
    McDonnell M, Evans N.
    J Paediatr Child Health; 1995 Apr 24; 31(2):152-4. PubMed ID: 7794619
    [Abstract] [Full Text] [Related]

  • 18. Lowest effective dose of dexamethasone in the respiratory care of very preterm infants.
    Tsukahara H, Mayumi M.
    Early Hum Dev; 2007 Jan 24; 83(1):3. PubMed ID: 16725285
    [No Abstract] [Full Text] [Related]

  • 19. Intestinal obstruction and perforation following sucralfate administration in a very low birth weight infant.
    Tang TS, Yeung CY.
    J Perinat Med; 1992 Jan 24; 20(4):317-21. PubMed ID: 1432557
    [Abstract] [Full Text] [Related]

  • 20. Weighing statistical certainty against ethical, clinical, and biologic expediency: the contributions of the Watterberg trial tip the scales in the right direction.
    Gordon PV.
    Pediatrics; 2005 May 24; 115(5):1446-7; author reply 1447. PubMed ID: 15867074
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.